Call (844) 879-2237

Request additional information regarding Cerafix®

A Material Development Company

A bioscience company commercializing a portfolio of fully synthetic electrospun scaffolds for medical applications

Feature image

The FDA cleared Acera’s first product in March 2016 and its second product in April 2017, both via 510(k). Acera is currently raising Series A financing, as well as seeking strategic partners for product development and commercialization.

Feature image
Premium WordPress Themes with Single Click

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Meshes
Biologic Properties

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Performance
Investment Opportunities

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Acera News

New Research Highlights Restrata® Wound Matrix Results

Acera Surgical Announces Positive Results from Clinical Study Examining The Use of Restrata® Wound Matrix In Healing Chronic Lower Extremity Wounds
St. Louis, MO—April 18, 2018— Acera Surgical Inc., the industry leader in implantable nanomedical scaffolds, has been selected to present […]

Read More
Post Image

Acera’s SAWC 2017 Poster

Read More